Carl Dambkowski - 23 Jan 2026 Form 4 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Carl Dambkowski
Issuer symbol
ORKA
Transactions as of
23 Jan 2026
Net transactions value
$0
Form type
4
Filing time
23 Jan 2026, 16:31:31 UTC
Previous filing
09 Jan 2026
Next filing
04 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dambkowski Carl Director C/O ORUKA THERAPEUTICS, INC., 855 OAK GROVE AVE., SUITE 100, MENLO PARK /s/ Paul Quinlan, as attorney-in-fact for Carl Dambkowski 23 Jan 2026 0001983476

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORKA Common Stock Other $0 +116,483 $0.000000 116,483 23 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the pro-rata distribution of shares of common stock for no consideration from a limited liability company in which the Reporting Person is a member.